肿瘤基础与临床
腫瘤基礎與臨床
종류기출여림상
JOURNAL OF BASIC AND CLINICAL ONCOLOGY
2014年
2期
147-148
,共2页
胸腔镜%氩氦刀%非小细胞肺癌%肿瘤标志物
胸腔鏡%氬氦刀%非小細胞肺癌%腫瘤標誌物
흉강경%아양도%비소세포폐암%종류표지물
thoracoscope%argon-helium knife%non-small cell lung cancer%tumor marker
目的：探讨晚期非小细胞肺癌（NSCLC）患者经胸腔镜辅助氩氦刀治疗前后血清 CEA、CYFRA21-1、CA125水平的变化。方法测定30例晚期 NSCLC 患者胸腔镜辅助氩氦刀治疗前后血清 CEA、CYFRA21-1、CA125的水平。结果胸腔镜辅助氩氦刀治疗后 NSCLC 患者血清 CEA、CYFRA21-1、CA125水平较治疗前显著下降（P 均<0.05）。结论晚期 NSCLC 患者经胸腔镜辅助氩氦刀治疗后可以下调 CEA、CYFRA21-1、CA125水平，通过监测其水平改变有助于手术疗效的评估。
目的：探討晚期非小細胞肺癌（NSCLC）患者經胸腔鏡輔助氬氦刀治療前後血清 CEA、CYFRA21-1、CA125水平的變化。方法測定30例晚期 NSCLC 患者胸腔鏡輔助氬氦刀治療前後血清 CEA、CYFRA21-1、CA125的水平。結果胸腔鏡輔助氬氦刀治療後 NSCLC 患者血清 CEA、CYFRA21-1、CA125水平較治療前顯著下降（P 均<0.05）。結論晚期 NSCLC 患者經胸腔鏡輔助氬氦刀治療後可以下調 CEA、CYFRA21-1、CA125水平，通過鑑測其水平改變有助于手術療效的評估。
목적：탐토만기비소세포폐암（NSCLC）환자경흉강경보조아양도치료전후혈청 CEA、CYFRA21-1、CA125수평적변화。방법측정30례만기 NSCLC 환자흉강경보조아양도치료전후혈청 CEA、CYFRA21-1、CA125적수평。결과흉강경보조아양도치료후 NSCLC 환자혈청 CEA、CYFRA21-1、CA125수평교치료전현저하강（P 균<0.05）。결론만기 NSCLC 환자경흉강경보조아양도치료후가이하조 CEA、CYFRA21-1、CA125수평，통과감측기수평개변유조우수술료효적평고。
Objective To investigate serum levels of CEA,CYFRA21-1 and CA125 in the advanced non-small cell lung cancer(NSCLC)before and after thoracoscope assisted argon-helium knife. Methods The serum levels of CEA,CYFRA21-1 and CA125 were measured in the 30 patients with advanced NSCLC before and after thoraco-scope assisted argon-helium knife. Results The serum levels of CEA,CYFRA21-1,CA125 in the patients with advanced NSCLC after thoracoscope assisted argon-helium knife were lower than those before thoracoscope assisted argon-helium knife(P < 0. 05). Conclusion Thoracoscope assisted argon-helium knife can decrease the serum levels of CEA,CYFRA21-1 and CA125 in the patients with advanced NSCLC,monitor of their levels could be help-ful to evaluate the effects of surgery.
